Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (41)

2024

  1. EAACI/ENDA position paper on drug provocation testing

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 565-579

  2. Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 552-564

2023

  1. Different Patterns of Response in Hypersensitivity Reactions to Arylpropionic Acid Derivatives

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 12, pp. 3715-3723

2022

  1. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2292-2312

2021

  1. Deep sequencing of prostaglandin-endoperoxide synthase (PTGE) genes reveals genetic susceptibility for cross-reactive hypersensitivity to NSAID

    British Journal of Pharmacology, Vol. 178, Núm. 5, pp. 1218-1233

  2. Diagnostic Approach of Hypersensitivity Reactions to Cefazolin in a Large Prospective Cohort

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 12, pp. 4421-4430.e4

  3. Genetic Variants Associated With Drug-Induced Hypersensitivity Reactions: towards Precision Medicine?

    Current Treatment Options in Allergy, Vol. 8, Núm. 1, pp. 42-59

  4. Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs

    Frontiers in Pharmacology, Vol. 12

  5. PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 9

  6. Polymorphisms in eicosanoid-related biosynthesis enzymes associated with acute urticaria/angioedema induced by nonsteroidal anti-inflammatory drug hypersensitivity

    British Journal of Dermatology, Vol. 185, Núm. 4, pp. 815-824

  7. The Role of Basophil Activation Test in Drug Allergy

    Current Treatment Options in Allergy, Vol. 8, Núm. 4, pp. 298-313

2020

  1. Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review—An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1069-1098

  2. Hypersensitivity Reactions to Multiple Iodinated Contrast Media

    Frontiers in Pharmacology, Vol. 11

  3. Promoter genotyping and mRNA expression– based analysis of the PTGDR gene in allergy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 2, pp. 117-126

  4. Recommendations for Diagnosing and Management of Patients with Perioperative Drug Reactions

    Current Treatment Options in Allergy, Vol. 7, Núm. 2, pp. 181-197

2019

  1. CRTH2 mRNA levels in peripheral blood of adult patients with nasal polyposis

    Allergy

2018

  1. Chromatin immunoprecipitation (ChIP)assays identify a functional retinoic acid receptorbinding site and−549T>C SNP in the PTGDR‐5′region

    Allergy

  2. NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs

    Scientific Reports, Vol. 8, Núm. 1

  3. Practical guidelines for perioperative hypersensitivity reactions

    Journal of Investigational Allergology and Clinical Immunology, Vol. 28, Núm. 4, pp. 216-232

  4. The Basophil Activation Test Can Be of Value for Diagnosing Immediate Allergic Reactions to Omeprazole

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, Núm. 5, pp. 1628-1636.e2